Cardiovascular Research Centre, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Cardiovascular Research Centre, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Biochim Biophys Acta Mol Basis Dis. 2020 Jul 1;1866(7):165771. doi: 10.1016/j.bbadis.2020.165771. Epub 2020 Mar 19.
Cannabis has been shown to be beneficial in the treatment of pain and inflammatory diseases. The biological effect of cannabis is mainly attributed to two major cannabinoids, tetrahydrocannabinol and cannabidiol. In the majority of studies to-date, a purified tetrahydrocannabinol and cannabidiol alone or in combination have been extensively examined in many studies for the treatment of numerous disorders including pain and inflammation. However, few studies have investigated the biological benefits of full-spectrum cannabis plant extract. Given that cannabis is known to generate a large number of cannabinoids along with numerous other biologically relevant products including terpenes, studies involving purified tetrahydrocannabinol and/or cannabidiol do not consider the potential biological benefits of the full-spectrum cannabis extracts. This may be especially true in the case of cannabis as a potential treatment of pain and inflammation. Herein, we review the pre-clinical physiological and molecular mechanisms in biological systems that are affected by cannabis.
大麻已被证明对治疗疼痛和炎症性疾病有益。大麻的生物学效应主要归因于两种主要的大麻素,即四氢大麻酚和大麻二酚。在迄今为止的大多数研究中,单独或联合使用纯化的四氢大麻酚和大麻二酚已在许多研究中广泛研究用于治疗包括疼痛和炎症在内的多种疾病。然而,很少有研究调查全谱大麻植物提取物的生物学益处。鉴于已知大麻会产生大量的大麻素以及许多其他具有生物学相关性的产物,包括萜烯,涉及纯化的四氢大麻酚和/或大麻二酚的研究并不考虑全谱大麻提取物的潜在生物学益处。在大麻作为疼痛和炎症的潜在治疗方法的情况下尤其如此。在此,我们回顾了受大麻影响的生物系统中的临床前生理和分子机制。